Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

Malaria

13 posts
NNovartis
Sub-Saharan Africa | Novartis
Read More

Sub-Saharan Africa | Novartis

  • 2026-11-10
Why does Novartis work in sub-Saharan Africa? Sub-Saharan Africa is home to some of the world’s fastest growing…
NNovartis
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Read More

Novartis ranks first place in 2026 Access to Medicine

  • 2026-11-10
Novartis retains first place ranking among 20 sector peers for efforts to improve access to medicinesFirst company to…
NNovartis
Novartis ranks No. 1 in 2026 Access to Medicine Index
Read More

Novartis ranks No. 1 in 2026 Access to Medicine Index

  • 2026-11-10
Breakthroughs only matter when you break down barriers to healthcare. In 2025, our medicines reached 300 million patients,…
NNovartis
Fortune includes Novartis in 2026 Change The World List for malaria program
Read More

Fortune includes Novartis in 2026 Change The World List for malaria program

  • 2026-09-23
Novartis has been named to Fortune’s Change the World 2026 list in recognition of our malaria program, one…
NNovartis
Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies
Read More

Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies

  • 2026-04-26
The first antimalarial developed specifically for babies is a step closer to reaching parts of the world where…
NNovartis
Novartis malaria treatment Coartem® Baby receives WHO prequalification
Read More

Novartis malaria treatment Coartem® Baby receives WHO prequalification

  • 2026-04-26
Novartis malaria treatment Coartem® Baby receives WHO prequalification April 26, 2026 | Sunday | News Coartem® (artemether-lumefantrine) Baby…
NNovartis
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
Read More

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

  • 2026-04-24
Coartem® (artemether-lumefantrine) Baby is the first and only malaria treatment for newborns and young infants, closing long-standing treatment…
NNovartis
Vas Narasimhan on his rise to Novartis CEO
Read More

Vas Narasimhan on his rise to Novartis CEO

  • 2026-03-16
Guided by immigrant roots, public‑health purpose and a belief in “staying in the ring,” Novartis CEO Vas Narasimhan…
NNovartis
Turning personal experience into purpose-driven careers
Read More

Turning personal experience into purpose-driven careers

  • 2026-03-10
For Arti, Giselle and Maria their desire for purpose began with a moment that changed everything and grew…
GGeneva
Global Fund boss warns aid cuts jeopardise progress against malaria
Read More

Global Fund boss warns aid cuts jeopardise progress against malaria

  • 2026-03-08
Climate change, conflicts and a lack of funding compounded by recent aid cuts are hurting hard-won gains in…
NNovartis
Breaking ground in Global Health
Read More

Breaking ground in Global Health

  • 2026-02-25
This past year has been active at Novartis in the malaria space. What has it meant for your…
NNovartis
Eden Wells | Novartis United States of America
Read More

Novartis receives approval for first malaria medicine for newborn babies and young infants

  • 2026-02-13
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight…
Switzerland
www.europesays.com